Ryan Barbara
SEC Form 4 insider trading activity
Ryan Barbara has filed 12 SEC Form 4 filings (18 transaction rows) across 2 companies, including INKT, INDV, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Ryan Barbara is listed as Director at MiNK Therapeutics, Inc. Inside the rolling window, Ryan Barbara reported 3 open-market purchases totaling $29K in INDV and 5 open-market sales totaling $47K in INKT. The largest disclosed transaction in the window is a purchase of 775 INDV shares on Jan 5, 2026, worth $27K.
Companies traded
Other insiders at INKT
Insider Buying
$29K
reported purchases (SEC code P)
Insider Selling
$47K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ryan Barbara made?
Ryan Barbara has filed 12 SEC Form 4 filings (18 transaction rows) across 2 companies, including INKT, INDV since 2025.
Which companies does Ryan Barbara trade?
Ryan Barbara has filed SEC Form 4 disclosures for 2 companies, including INKT, INDV.
When was Ryan Barbara's most recent SEC Form 4 filing?
Ryan Barbara's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Ryan Barbara's total buy and sell value in the current window?
Inside the rolling retention window, Ryan Barbara bought $29K and sold $47K based on SEC Form 4 filings.
What was Ryan Barbara's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 775 INDV shares on 2026-01-05, worth $27K, per SEC Form 4 filings.